Previous Article | Next Article ![]()
Journal of Clinical Microbiology, February 2009, p. 485-488, Vol. 47, No. 2
0095-1137/09/$08.00+0 doi:10.1128/JCM.01678-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.

Departments of Biochemistry,1 Hepatology, Hospital Universitario Vall d'Hebron, Barcelona, Spain,2 Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Barcelona, Spain3
Received 29 August 2008/ Returned for modification 8 October 2008/ Accepted 22 November 2008
A line probe assay (INNO-LiPA DR, version 3) for the detection of hepatitis B virus mutations that confer resistance to entecavir therapy was evaluated. The INNO-LiPA DR assay is a highly sensitive assay that is easily applicable for the detection and monitoring of entecavir resistance-conferring mutations and is more sensitive than sequencing for the detection of mixed sequences.
Published ahead of print on 3 December 2008.
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»